EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns

Natalie G Alexander, William D Cutts iD, Thomas A Hooven, Brandon J Kim

Journal of the Pediatric Infectious Diseases Society · 06.02.2025 · 14 (2)

DOI: 10.1093/jpids/piae103 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 10.02.2025. Verfasst von Natalie G Alexander und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Streptococcal Infections, Meningitis, Bacterial. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NINDS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group B Streptococcus (GBS; Streptococcus agalactiae) is a gram-positive colonizer of the healthy intestinal and genitourinary microbiota. During and shortly after birth, neonates and infants can be opportunistically infected leading to sepsis, pneumonia, or meningitis among other illnesses. GBS is the leading cause of neonatal meningitis globally, and while prophylactic treatments have been successful for reducing early-onset disease, no decrease in the incidence of late-onset disease has occurred and no vaccine is currently available. In this review, we describe GBS both from a clinical and molecular standpoint. We first describe the history of GBS perinatal disease and its clinical presentation and treatment, as well as patient outcomes. We then present recently discovered GBS interactions at the blood–brain barrier that contribute to disease and inflammatory responses, and efforts to develop a broadly effective GBS vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus agalactiaeStreptococcal InfectionsMeningitis, BacterialHumansInfant, NewbornBlood-Brain BarrierStreptococcal Vaccines

Stichwörter der Autor:innen

Streptococcusblood–brain barrierclinical outcomeshost–pathogen interactionsmeningitis

Substanzen

Streptococcal Vaccines

Autor:innen und Institutionen

  • Department of Biological Sciences, University of Alabama, Tuscaloosa, Alabama, USA.
  • Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Richard King Mellon Institute for Pediatric Research, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Center for Convergent Biosciences and Medicine, University of Alabama, Tuscaloosa, Alabama, USA.

ORCID-Profile: William D Cutts

Förderung

  • NIAID NIH HHS
  • NINDS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Alexander, N. G., Cutts, W. D., Hooven, T. A., & Kim, B. J. (2025). Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns. Journal of the Pediatric Infectious Diseases Society, 14(2). https://doi.org/10.1093/jpids/piae103

Vancouver

Alexander NG, Cutts WD, Hooven TA, Kim BJ. Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns. Journal of the Pediatric Infectious Diseases Society. 2025;14(2). doi:10.1093/jpids/piae103

BibTeX
@article{Alexander2025,
  author = {Alexander, Natalie G and Cutts, William D and Hooven, Thomas A and Kim, Brandon J},
  title = {Mechanisms and Manifestations of Group B Streptococcus Meningitis in Newborns},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  volume = {14},
  number = {2},
  doi = {10.1093/jpids/piae103}
}
Kostenlos starten →